Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0L3RY
|
||||
Former ID |
DNC007404
|
||||
Drug Name |
3-methoxy-N-(4-methylthiazol-2-yl)benzamide
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [528186] | ||
Structure |
Download2D MOL |
||||
Formula |
C12H12N2O2S
|
||||
Canonical SMILES |
CC1=CSC(=N1)NC(=O)C2=CC(=CC=C2)OC
|
||||
InChI |
1S/C12H12N2O2S/c1-8-7-17-12(13-8)14-11(15)9-4-3-5-10(6-9)16-2/h3-7H,1-2H3,(H,13,14,15)
|
||||
InChIKey |
PAGPVSQZNPBQLP-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Metabotropic glutamate receptor 5 | Target Info | Inhibitor | [528186] | |
mRNA of human 5-lipoxygenase | Target Info | Inhibitor | [528805] | ||
KEGG Pathway | Calcium signaling pathway | ||||
Neuroactive ligand-receptor interaction | |||||
Gap junction | |||||
Long-term potentiation | |||||
Retrograde endocannabinoid signaling | |||||
Glutamatergic synapse | |||||
Huntington's diseasehsa00590:Arachidonic acid metabolism | |||||
Metabolic pathways | |||||
Serotonergic synapse | |||||
Ovarian steroidogenesis | |||||
Toxoplasmosis | |||||
NetPath Pathway | IL4 Signaling Pathway | ||||
PathWhiz Pathway | Arachidonic Acid Metabolism | ||||
References | |||||
Ref 528186 | Bioorg Med Chem Lett. 2006 Jul 1;16(13):3371-5. Epub 2006 May 5.Design and synthesis of noncompetitive metabotropic glutamate receptor subtype 5 antagonists. | ||||
Ref 528805 | J Med Chem. 2007 May 31;50(11):2640-6. Epub 2007 Apr 27.Identification of natural-product-derived inhibitors of 5-lipoxygenase activity by ligand-based virtual screening. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.